BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,658,150 | +34.7% | 8,790,000 | +37.1% | 0.00% | 0.0% |
| Q2 2023 | $6,426,026 | +127.8% | 6,410,000 | +144.2% | 0.00% | – |
| Q4 2022 | $2,820,694 | +1832.0% | 2,625,000 | +1697.9% | 0.00% | – |
| Q3 2022 | $146,000 | +121.2% | 146,000 | +121.2% | 0.00% | – |
| Q2 2022 | $66,000 | -87.6% | 66,000 | -87.5% | 0.00% | – |
| Q1 2022 | $531,000 | -13.1% | 530,000 | -9.6% | 0.00% | – |
| Q4 2021 | $611,000 | +6.3% | 586,000 | +0.9% | 0.00% | – |
| Q3 2021 | $575,000 | +147.8% | 581,000 | +151.5% | 0.00% | – |
| Q2 2021 | $232,000 | – | 231,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |